Who owns Orikine Bio?

Orikine Bio is currently owned by AdBio Partners, through AFB Fund I, since 2026.

When did AdBio Partners acquire Orikine Bio?

AdBio Partners acquired Orikine Bio in 2026 (active for 0 years).

Home/Companies/Healthcare/Orikine Bio

Orikine Bio

Healthcare·

Spain·Active·0yr hold

Orikine Bio is a healthcare company, headquartered in Spain.

Entry

2026

Hold

0yr

Status

Active

Est. EV

–

Investor

AdBio Partners

Key facts

HQSpain

SectorHealthcare

Develops novel therapeutics. Seed €5.5M co-invested with Sabadell Asabys. Jan 2026: confirmed latest investment by AdBio (30-Jan-2026 per…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from AFB Fund I

Other portfolio companies in the same fund.

Augustine Therapeutics

Active

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings